Patel Dinesh V PH D's Form 4 filing
Protagonist Therapeutics, Inc (PTGX) · filed May 12, 2026
- Accession no.
- 0001104659-26-059591
- Filed
- May 12, 2026
- Trade date
- May 12, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.51M. It was filed on the trade date.
This filing was later replaced by the amendment 0001104659-26-061476 (May 14, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Dinesh V PH DCIK 0001120477 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Common Stock | MOption exerciseAcquired | +75,000 | $21.58 | +$1,618,500 | 598,478 | Direct | |
| May 12, 2026 | Common Stock | SSaleDisposed | −75,000 | $100.12 | −$7,509,000 | 523,478 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Common Stock | MOption exerciseDisposed | −75,000 | $0.00 | $0 | 225,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.